Newsline
Thursday, December 27, 2012
Gene Therapy Cocktail Shows Promise for Rare Fatal Brain Disorder
Results of a clinical trial that began in 2001 show that a gene therapy cocktail conveyed into the brain by a molecular special delivery vehicle may help extend the lives of children with Canavan disease, a rare and fatal neurodegenerative disorder. …
Click here to read more
Thursday, December 27, 2012
‘Heads Up, Don’t Duck,’ Say Mayo Clinic, USA Hockey to Youth Hockey Players
As youth hockey players fly toward the boards, they almost instinctively duck their heads, which is exactly the wrong thing to do. According to experts, this fast-paced sport can be safer if players follow some simple advice. USA Hockey, the national …
Click here to read more
Wednesday, December 26, 2012
Alzheimer’s Patients Without Spouses Are Less Represented in Clinical Trials
A new study suggests that people without a spouse are underrepresented in Alzheimer’s disease clinical trials when compared to people with spouses. The study appears in the Dec. 19, 2012, online issue of Neurology, the medical journal of the American …
Click here to read more
Wednesday, December 26, 2012
Study Reveals Disconnect Between Surgeons, Patients About Life Support
In a nationwide survey of more than 900 vascular, cardiothoracic and neurological surgeons, 60 percent of respondents said they would either sometimes or always refuse to operate on a patient who explicitly stated a desire to limit life-supporting treatments …
Click here to read more
Tuesday, December 25, 2012
MRIs Show Signs of Mild Traumatic Brain Injuries Not Found in CT Scans
Hospital MRIs may be better at predicting long-term outcomes for people with mild traumatic brain injuries than CT scans, the standard technique for evaluating such injuries in the emergency room — that’s according to a clinical trial from researchers …
Click here to read more
Monday, December 24, 2012
Cancer Patients May Not be Receiving Best Treatment for Debilitating Fatigue
Many people who have been through cancer and its treatment have trouble with their recovery due to severe, debilitating fatigue that can last for months or even years. But even though a variety of treatments exist for cancer-related fatigue, few doctors …
Click here to read more
Friday, December 21, 2012
Johns Hopkins’ Armstrong Institute to Help The Leapfrog Group Grade Safety, Quality of U.S. Hospitals
A team of researchers at Johns Hopkins’ Armstrong Institute for Patient Safety and Quality has been selected to provide scientific guidance to The Leapfrog Group — a national nonprofit known for publishing report cards detailing how hospitals perform …
Click here to read more
Thursday, December 20, 2012
Methodist Hospital, Remeditex Ventures LLC Developing Brain Tumor Drug
The Methodist Hospital in Houston and Dallas-based Remeditex Ventures LLC have entered into an exclusive agreement to develop an investigational drug for glioblastomas, the most malignant of all primary brain cancers. Current treatments only prolong …
Click here to read more
Thursday, December 20, 2012
Study Finds Further Evidence That Vitamin D Reduces Risk of Autism
A study just published online in the peer-reviewed journal Dermato-Endocrinology found additional evidence that vitamin D reduces the risk of developing autism. The study examined the variation of autism prevalence by state for those aged 6-17 years …
Click here to read more
Wednesday, December 19, 2012
Scientist Receives $3 Million Grant to Study Most Common Inherited Neurological Disorder
A Cedars-Sinai physician-scientist has been awarded a $3 million grant from the California Institute for Regenerative Medicine to study Charcot-Marie-Tooth disease using new stem cell technology, the most common inherited neurological disorder, which …
Click here to read more